| CTRI Number |
CTRI/2025/11/096912 [Registered on: 04/11/2025] Trial Registered Prospectively |
| Last Modified On: |
03/11/2025 |
| Post Graduate Thesis |
Yes |
| Type of Trial |
Interventional |
|
Type of Study
|
Drug Ayurveda |
| Study Design |
Single Arm Study |
|
Public Title of Study
|
A Study on Ayurvedic Treatment for Ardhavbhedaka (Migraine) Using Laghu Sutshekhar Ras, Anu Taila Nasya and Pathyadi Kwath |
|
Scientific Title of Study
|
A Single Arm Open Label Clinical Study to Evaluate the Efficacy of Laghu Sutshekhar Ras and Anu Taila Nasya along with Pathyadi Kwath in the Management of Ardhavbhedaka (Migraine) |
| Trial Acronym |
NIL |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Dr Vandana Saini |
| Designation |
PG Scholar MS Shalakya Tantra |
| Affiliation |
Institute for Ayurved Studies and Research Kurukshetra Haryana |
| Address |
OPD No 54 and 50 Department of Shalakya Tantra Institute for Ayurved Studies and Research Umri Road Sector 8 Kurukshetra Haryana
Kurukshetra HARYANA 136118 India |
| Phone |
7696015642 |
| Fax |
|
| Email |
vandanasaini942@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
Dr Manoj Kumar |
| Designation |
Professor , Department of Shalakya Tantra |
| Affiliation |
Institute for Ayurved Studies and Research Kurukshetra Haryana |
| Address |
Room no 109 PG Department of Shalakya Tantra Institute for Ayurved Studies and Research Umri Road Sector 8 Kurukshetra Haryana
136118
India
Kurukshetra HARYANA 136118 India |
| Phone |
9996310888 |
| Fax |
|
| Email |
drmanojtanwar23@gmail.com |
|
Details of Contact Person Public Query
|
| Name |
Dr Vandana Saini |
| Designation |
PG Scholar MS Shalakya Tantra |
| Affiliation |
Institute for Ayurved Studies and Research Kurukshetra Haryana |
| Address |
OPD No 54 and 50 Department of Shalakya Tantra Institute for Ayurved Studies and Research Umri Road Sector 8 Kurukshetra Haryana
Kurukshetra HARYANA 136118 India |
| Phone |
7696015642 |
| Fax |
|
| Email |
vandanasaini942@gmail.com |
|
|
Source of Monetary or Material Support
|
| Institute for Ayurved Studies and Research Sector 8 Kurukshetra, Haryana, India
Pincode 136118 |
|
|
Primary Sponsor
|
| Name |
Institute for Ayurved Studies and Research |
| Address |
Umri Road Sector 8 Kurukshetra |
| Type of Sponsor |
Other [Government Ayurvedic College] |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr Vandana Saini |
Institute for Ayurved Studies and Research Hospital |
OPD No 54 and 50 Department of Shalakya Tantra Institute for Ayurved Studies and Research Umri Road Sector 8 Kurukshetra Haryana
Kurukshetra
HARYANA
136118
India Kurukshetra HARYANA |
7696015642
vandanasaini942@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| Institutional Ethics Committee Shri Krishna Ayush University Kurukshetra |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition:G430||Migraine without aura. Ayurveda Condition: ARDHAVABEDAKAH, |
|
|
Intervention / Comparator Agent
|
| sno | Intervention/Comparator | Type | Drug-Type | Procedure Name | Details | | 1 | Intervention Arm | Procedure | - | nasyam/ nastam, नस्यम्/ नस्तम् | (Procedure Reference: Charak Samhita Vidyotini, Sutra Sathana 5 for Anu Taila Prepration. , Procedure details: Procedure will be done for 21 days
3 Sittings of Nasya i.e 7days each with an interval of 7 days in between.
) (1) Medicine Name: Anu Taila, Reference: Charak Samhita Vidyotini, Sutra Sathana 5 , Route: Nasal, Dosage Form: Bindu/ Drops/ Spray (Karna/ Nasa/ Netra/ Mukha), Dose: 8(drops), Frequency: od, Duration: 21 Days | | 2 | Intervention Arm | Drug | Classical | | (1) Medicine Name: Laghu Sutshekhar Ras, Reference: Rasatantra Sara Siddha Prayog Sangrah , Route: Oral, Dosage Form: Gutika/Vati/Ghana Vati/ Tablets, Dose: 500(mg), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 35 Days, anupAna/sahapAna: No, Additional Information: -(2) Medicine Name: Pathyadi Kwath, Reference: Bhavaprakash madhyamkhanda ,Shirorogadhikar, Route: Oral, Dosage Form: Kwatha/ Kashaya, Dose: 50(ml), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 35 Days, anupAna/sahapAna: Yes(details: - Guda), Additional Information: - |
|
|
|
Inclusion Criteria
|
| Age From |
18.00 Year(s) |
| Age To |
50.00 Year(s) |
| Gender |
Both |
| Details |
Patients with sign and symptoms of Ardhavabhedaka (Migraine with or without aura) will be selected irrespective of Sex, Religion and Profession.
Patients those are fit for Nasya Karma according to Ayurveda text.
Patients who have given written consent to participate in the study.
|
|
| ExclusionCriteria |
| Details |
Age group less than 18 years and more than 50 years.
The patient having any systemic illness, like - Diabetes mellitus, Hypertension, Tuberculosis, Hypotension & fever etc.
Patients suffering from head injury, and other type of headaches except migraine.
Patients Contraindicated for Nasya Karma.
Patients unwilling to provide written consent for participation are excluded.
Pregnant and lactating mothers.
Secondary headache caused by sinusitis, meningitis, brain tumour, encephalitis, cervical spondylitis etc.
Patients with any inflammatory disease.
Patients requiring surgical treatment (eg- for nasal polyp).
Patients with alcohol, opioids other drug addiction and using any other systemic drugs which may alter the result of study.
|
|
|
Method of Generating Random Sequence
|
Not Applicable |
|
Method of Concealment
|
Not Applicable |
|
Blinding/Masking
|
Open Label |
|
Primary Outcome
|
| Outcome |
TimePoints |
Significant improvement in signs and symptoms of Ardhavbhedaka (Migraine).
|
Follow up of patient will be done on 15th, 35th day of the treatment.
|
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
| Improvement in mental & physical well being of patient. |
Follow up on 15th , 30th day after treatment .
|
|
|
Target Sample Size
|
Total Sample Size="30" Sample Size from India="30"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
Phase 2 |
|
Date of First Enrollment (India)
|
01/12/2025 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="1" Months="6" Days="0" |
|
Recruitment Status of Trial (Global)
|
Not Applicable |
| Recruitment Status of Trial (India) |
Not Yet Recruiting |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
|
Brief Summary
|
The present study entitled A Single Arm Open Label Clinical Study to Evaluate the Efficacy of Laghu Sutshekhara Ras and Anu Taila Nasya along with Pathyadi Kwath in the Management of Ardhavbhedaka (Migraine) will be conducted to assess the effectiveness of Ayurvedic formulations in relieving migraine symptoms.
Ardhavbhedaka, described in Ayurvedic texts, closely resembles migraine, which is characterized by recurrent unilateral headaches often accompanied by nausea, vomiting, and photophobia. In this study, patients diagnosed with Ardhavbhedaka will be treated with Laghu Sutshekhara Ras orally, Anu Taila Nasya as nasal therapy, and Pathyadi Kwath as an adjuvant for a specific duration. The study will be conducted on 30 patients from opd/ipd of Institute for Ayurved Studies and Research Hospital, Kurukshetra Haryana.
The study follow a single-arm, open label design, allowing direct observation of therapeutic outcomes. Assessment will be done before and after treatment based on the frequency, duration, and intensity of headache attacks, as well as associated symptoms. |